Concept for feasibility review
Craneed Cranberry Extract 750 mg
TabletWomen's Health
Concept status
Preliminary Craneed Cranberry Extract 750 mg tablet concept for project-specific commercial and regulatory feasibility review. This is not a licensed, approved, or ready-to-order Canadian product.
Preliminary source ingredients
Ingredients: Cranberry Extract 25:1 (Produced from 18.75g cranberries) 750 mg. Other Ingredients: Lactose, Starch, PVP K-30, Magnesium Stearate, Talcum, Dicalcium Phosphate, Cross Carmellose Sodium.
Directions status
No Canadian directions for use have been established.
Directions and dosing are not established. They require formula, monograph, evidence, population, risk, and label review for the specific project.
Market assessment status
No public market-equivalence assessment has been completed for this preliminary concept.
Assess this concept for your project
Tell us your market, target format, quantities, timing, and current regulatory status. We will scope the commercial and regulatory feasibility review.